Table 1.
Presentation | Month 1–2 | Month 3 | Month 6 (> 5 months) |
|
---|---|---|---|---|
LogMar visual acuity | 0.79 ± 0.93 | 0.11 ± 0.27 | 0.06 ± 0.20 | 0.02 ± 0.10 |
Visual field MD, dB | −17.15 ± 10.80 | −3.72 ± 6.50 | −1.98 ± 2.43 | −1.06 ± 1.67 |
Days from vision loss | 7 ± 3.4 | 38 ± 13.3 | 129 ± 35.5 | 304 ± 128.2 |
GCL+IPL thickness, μm 3-D method |
82.4 ± 8.8 | 72.3 ± 9.7 | 72.5 ± 12.0 | 69. ± 11.6 |
GCL+IPL thickness, μm 2-D method |
81.2 ± 14.1 | 73.6 ± 8.3 | 72.0 ± 12.0 | 69.8 ± 10.2 |
RNFL thickness, μm 2-D method |
114.4 ± 43.4 | 99.1 ± 18.0 | 87.0 ± 11.7 | 84.1 ± 11.2 |
GCL+IPL thinning from prior visit, μm 3-D method |
9.9 ± 60* | 3.0 ± 3.0** | 0.2 ± 1.2*** |
At presentation, unaffected fellow eyes had mean GCL+IPL for 2-D method = 82.1 ± 6.7 μm and for 3-D method = 82.2 ± 7.0 μm, and pRNFL = 91.1 ± 9.8 μm
One subject had the first follow up at six months
Range 26.0 μm, Maximum 27.1, Minimum 1.1
Range 12.0 μm, Maximum 11.0, Minimum 0
Range 6.0 μm, Maximum 2.0, Minimum 0